Bloody diarrhea (often severe, though stool frequency may suddenly decrease as colonic distension worsens).
Diffuse, severe abdominal pain with localized/generalized peritoneal signs (rebound, guarding).
Diagnosis
Ogilvie Syndrome:
Initial: Abdominal X-ray (KUB) showing diffuse colonic dilation (typically cecum and right colon) with gas in the rectum/sigmoid.
Confirmatory/Best: CT scan of abdomen/pelvis (with oral/IV contrast) to confirm diffuse colonic dilation and exclude mechanical obstruction (no transition point/mass).
Key Labs: BMP (rule out hypokalemia, hypomagnesemia), TFTs (exclude hypothyroidism).
Critical Threshold: Cecal diameter >10–12 cm indicates high risk of impending ischemia and rupture.
Toxic Megacolon:
Initial/Best: Abdominal X-ray (KUB) showing colonic dilation (typically transverse colon >6 cm) with loss of normal haustra and “thumbprinting” (mucosal edema).
Key Labs: CBC (marked leukocytosis with left shift, anemia), ESR/CRP (highly elevated), BMP, stool PCR for C. diff.
Contraindicated: Complete colonoscopy and barium enema are strictly contraindicated due to extreme risk of perforation.
Differential Diagnostics
Mechanical Large Bowel Obstruction (LBO):
Differentiating features: CT shows a clear transition point and a mechanical cause (e.g., neoplasm, stricture, fecal impaction).
Sigmoid/Cecal Volvulus:
Differentiating features: KUB shows pathognomonic “coffee bean” sign (sigmoid) or “bird’s beak” sign on gastrografin enema.
Paralytic Ileus:
Differentiating features: Uniform dilation of both the small and large intestines (stomach, small bowel, and colon) with minimal focal cecal dilation; typically resolves spontaneously within 3 days postoperatively. c
Ogilvie vs. Toxic Megacolon:
Differentiating features: Toxic megacolon presents with severe systemic toxic signs (fever, shock, marked leukocytosis) and underlying active mucosal inflammation/colitis, whereas Ogilvie presents in critically ill pts without active colitis or toxic signs unless perforation has occurred.
Management
Ogilvie Syndrome:
First-line (Conservative):
Indicated if cecal diameter is <10–12 cm and no peritoneal signs.
NPO, NG tube for gastric decompression, and rectal tube.
Discontinue all offending meds (opiates, anticholinergics).
Frequent mobilization/repositioning (prone or knee-chest position).
Second-line (Pharmacologic):
Indicated if failed 24–48 hours of conservative tx OR cecal diameter >12 cm.
Neostigmine IV (acetylcholinesterase inhibitor).
Safety protocol: Requires continuous ECG and BP monitoring due to risk of severe bradycardia, bronchospasm, and salivation. Keep Atropine at bedside.
Third-line (Endoscopic):
Endoscopic colonic decompression (colonoscopy without bowel prep/minimal air insufflation) if neostigmine is contraindicated (e.g., active bronchospasm, bradycardia, recent MI, or mechanical obstruction) or fails.
Refractory/Emergent (Surgical):
Surg cecostomy or colectomy if there are signs of ischemia, gangrene, perforation, or peritonitis.
Toxic Megacolon:
First-line (Medical Stabilization):
Aggressive IV fluid resuscitation, bowel rest (NPO), and NG tube decompression.
Broad-spectrum IV antibiotics (e.g., Ceftriaxone + Metronidazole, or Piperacillin-Tazobactam) to cover bowel flora and prevent translocation sepsis.
If secondary to IBD flare: High-dose IV Corticosteroids (Methylprednisolone).
If secondary to C. diff: Oral/rectal Vancomycin + IV Metronidazole.
Second-line/Emergent (Surgical):
Subtotal colectomy with end ileostomy is the definitive tx.
Indications: Perforation, peritonitis, massive lower GI hemorrhage, or failure to clinically improve within 24–72 hours of intensive medical tx.
Complications
Colonic Perforation: Most common in the cecum (Ogilvie) or transverse colon (Toxic Megacolon); leads to high mortality.
Ischemia and Gangrene: Resulting from elevated intraluminal pressure compromising intramural blood flow.
Fecal Peritonitis & Sepsis: Can rapidly progress to septic shock and Multi-Organ Dysfunction Syndrome (MODS).
Abdominal Compartment Syndrome: Due to massive, tense colonic distension causing respiratory compromise and renal impairment.